Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A model for breast cancer screening.

G J van Oortmarssen1, J D Habbema, P J van der Maas

  • 1Department of Public Health and Social Medicine, Erasmus University, Rotterdam, The Netherlands.

Cancer
|October 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A mobile-based randomized controlled trial on the feasibility and effectiveness of screening for major depressive disorder: study protocol.

BMC psychology·2024
Same author

A validated Screening instrument for Child Abuse and Neglect (SCAN) at the emergency department.

European journal of pediatrics·2022
Same author

Socio-economic inequality of utilization of cancer testing in Europe: A cross-sectional study.

Preventive medicine reports·2022
Same author

Cost-effectiveness of HPV-based cervical screening based on first year results in the Netherlands: a modelling study.

BJOG : an international journal of obstetrics and gynaecology·2020
Same author

Contamination in control group led to no effect of PSA-based screening on prostate cancer mortality at 9 years follow-up: Results of the French section of European Randomized Study of Screening for Prostate Cancer (ERSPC).

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2020
Same author

Reasons for (non)participation in supplemental population-based MRI breast screening for women with extremely dense breasts.

Clinical radiology·2018

A new breast cancer screening model accurately predicts detection rates and mortality reduction. It utilizes preclinical stage duration and mammography sensitivity to evaluate screening policies effectively.

Area of Science:

  • Oncology
  • Medical Imaging
  • Public Health

Background:

  • Breast cancer screening is crucial for early detection and improved outcomes.
  • Existing screening programs face challenges in optimizing detection rates and minimizing interval cancers.
  • Accurate modeling is needed to evaluate the effectiveness of different screening strategies.

Purpose of the Study:

  • To develop and validate a mathematical model for breast cancer screening.
  • To assess the model's ability to replicate observed detection rates and interval cancer incidence.
  • To evaluate the model's prediction of mortality reduction compared to real-world trials.

Main Methods:

  • A simulation model was developed incorporating key parameters like preclinical stage duration and mammography sensitivity.

Related Experiment Videos

  • The model was calibrated using data from screening projects in Utrecht and Nijmegen, Netherlands.
  • Model predictions for mortality reduction were compared with results from the Kopparberg/Ostergötland randomized trial.

    • Main Results:

    • The model successfully reproduced detection rates and interval cancer incidence from Dutch screening projects.
    • Preclinical stage duration varies with age, increasing from approximately 2 years at age 40 to 5 years at age 70.
    • Mammography sensitivity is high (around 95%) for tumors exceeding 1 cm.
    • Model predictions for mortality reduction align with findings from the Swedish randomized trial.

    Conclusions:

    • The developed breast cancer screening model is a valuable tool for evaluating screening policies.
    • The model accurately reflects key epidemiological parameters of breast cancer.
    • It can be used prospectively to assess the effects and costs of various screening strategies, aiding in public health decision-making.